McKesson Corporation · NYSE:MCK

McKesson — Citi Global Healthcare Conference (February 2014)

30 slides from McKesson's conference presentation, Feb 25, 2014

  1. Slide 1: McKesson: In Business for Better Health

    McKesson: In Business for Better Health Citi Global Healthcare Conference James Beer Executive Vice President and Chief Financial Officer McKesson Corporation February 25, 2014

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements Some of the information in this presentation is not historical in nature and may GAAP / Non-GAAP constitute forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Reconciliation These state

  3. Slide 3: McKesson At-a-Glance

    McKesson At-a-Glance Driving Better Health for 180 years • Headquartered in San Francisco, CA Unless indicated otherwise, presentation reflects results as of FYE13. 3

  4. Slide 4: McKesson Drives Sustained Value Creation

    McKesson Drives Sustained Value Creation Attractive healthcare markets Experienced and tenured management • Public policy agenda supports greater access and improved efficiency team with a steady • Demographics drive long-term demand track record of delivering results Strong balance Well-positioned

  5. Slide 5: Leadership Positions In Both Segments

    Leadership Positions In Both Segments Distribution Technology Solutions Solutions #1 pharmaceutical distributor #1 in medical-management software in U.S. and Canada and services to payers #1 in medical-surgical distribution Leading RelayHealth claims-processing to alternate care sites and connectivi

  6. Slide 6: We Have A Track Record Of Steady Revenue Growth

    We Have A Track Record Of Steady Revenue Growth… $ Billions $122 $122 $108 $112 $101 $106 $93 FY07 FY08 FY09 FY10 FY11 FY12 FY13 Revenues for fiscal years 2007 through 2013 from continuing operations. 6

  7. Slide 7: Leveraged Into Higher Adjusted EPS Growth

    …That We Have Leveraged Into Higher Adjusted EPS Growth… FY14 Guidance $8.05 - $8.20 $6.28 $6.38 $4.65 $5.13 $4.23 $3.41 $2.81 FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 Reflects non-GAAP information calculated on an Adjusted Earnings basis. Reconciliation to GAAP information for fiscal years 2007 thro

  8. Slide 8: And Solid Results Through Third Quarter

    … And Solid Results Through Third Quarter Fiscal 2014 (In Millions except Adjusted EPS) Nine Months Ended December 31, 2013 2012 Chg Revenues Distribution Solutions $ 97,094 $ 89,347 9% Technology Solutions 2,374 2,206 8% $ 99,468 $ 91,553 9% Adjusted Operating Profit Distribution Solutions $ 2,310

  9. Slide 9: We've Steadily Increased Operating Cash Flow

    We’ve Steadily Increased Operating Cash Flow 7-Year Moving Average $2.5 $2.0 OCF $ Billions $1.5 $1.0 $0.5 FY07 FY08* FY09 FY10 FY11 FY12 FY13 *FY08 excludes $962 million Securities Litigation payment. 9

  10. Slide 10: A History Of Effective Capital Deployment

    And We Have A History Of Effective Capital Deployment $8.8B in Value-Creating FY07 – FY13 $ Billions Acquisitions from FY07 – FY13 $0.9 Dividends Internal Capital PSS World Medical $1.9B Spending • Expanding medical surgical reach and capabilities $2.6 Drug Trading - Katz $0.9B $8.8 • Solidifying ma

  11. Slide 11: PSS World Medical Integration Update

    PSS World Medical Integration Update Salesforce Engagement Synergies Leadership Integration 11

  12. Slide 12: Expanding Global Reach

    MCKESSON Expanding Global Reach

  13. Slide 13: Celesio Overview

    Celesio Overview More Positive Lives • Founded in 1835 and listed since 1904 • Headquartered in Stuttgart, Germany • Operates in 14 countries • 39,000 employees Financials*: • Extensive network of pharmacies in Europe FY12 Revenue: € 22.3 B • Leading positions as a pharmaceutical distributor in Euro

  14. Slide 14: Planned Transaction Timeline

    Planned Transaction Timeline F4Q 2014 F1Q 2015 F2Q 2015 ending March 31, 2014 beginning April 1, 2014 beginning July 1, 2014 • Achieves ownership of >75% • Operational control expected of diluted shares late in 1H FY15 • McKesson begins to consolidate financial results of Celesio • Domination proces

  15. Slide 15: Combination Drives Value Creation

    Combination Drives Value Creation • Expected accretion to Adjusted Earnings per share of $1.00 to $1.20 in the Accretion first twelve months • Assumes 100% ownership of Celesio • Anticipated annual synergies between $275 million and $325 million realized Synergies by the fourth year following the co

  16. Slide 16: Creating A Global Healthcare Services Leader

    Creating A Global Healthcare Services Leader • 120,000 pharmacy and hospital delivery locations • 11,000+ community pharmacies • 82,500 employees worldwide • $150+ billion in annual revenues 16

  17. Slide 17: Global Sourcing Excellence

    Global Sourcing Excellence ENGLAND GERMANY CANADA POLAND IRELAND HUNGARY SPAIN SLOVENIA USA ITALY MALTA ISRAEL CHINA SOUTH KOREA BERMUDA INDIA TAIWAN BRITISH VIRGIN HONG ISLANDS KONG PHILIPPINES THAILAND MALAYSIA Europe India China ENGLAND GERMANY POLAND IRELAND HUNGARY SOUTH SPAIN KOREA SLOVENIA IT

  18. Slide 18: Driving Supply Chain Efficiencies

    Expanded Distribution Agreement With Rite Aid OneStopSM Generics Sourcing Expertise Driving Supply Chain Efficiencies 18

  19. Slide 19: In Business For Better Health

    In Business For Better Health 19

  20. Slide 20: McKesson

    MCKESSON

  21. Slide 21: Appendix

    MSKESSON Appendix BUSINESS CARE CONNECTIVITY )

  22. Slide 22: Adjusted Earnings (Non-GAAP) Financial Information

    Adjusted Earnings (Non-GAAP) Financial Information The Company believes the presentation of non‐GAAP measures such as Adjusted Earnings provides useful supplemental information to investors with regard to its core operating performance, as well as assists with the comparison of its past financial pe

  23. Slide 23: GAAP/Adjusted Earnings (Non-GAAP) Reconciliation

    GAAP/Adjusted Earnings (Non-GAAP) Reconciliation McKESSON CORPORATION RECONCILIATION OF GAAP OPERATING RESULTS TO ADJUSTED EARNINGS (NON-GAAP) FOR FISCAL 2007 THROUGH NINE MONTHS ENDED DECEMBER 31, 2013 (unaudited) (in millions, except per share amounts) Nine Months Ended December 31, 2013 Amortizat

  24. Slide 24: GAAP/Adjusted Earnings (Non-GAAP) Reconciliation

    GAAP/Adjusted Earnings (Non-GAAP) Reconciliation McKESSON CORPORATION RECONCILIATION OF GAAP OPERATING RESULTS TO ADJUSTED EARNINGS (NON-GAAP) FOR FISCAL 2007 THROUGH NINE MONTHS ENDED DECEMBER 31, 2013 (unaudited) (in millions, except per share amounts) Year Ended March 31, 2013 (a) Amortization Ac

  25. Slide 25: GAAP/Adjusted Earnings (Non-GAAP) Reconciliation

    GAAP/Adjusted Earnings (Non-GAAP) Reconciliation McKESSON CORPORATION RECONCILIATION OF GAAP OPERATING RESULTS TO ADJUSTED EARNINGS (NON-GAAP) FOR FISCAL 2007 THROUGH NINE MONTHS ENDED DECEMBER 31, 2013 (unaudited) (in millions, except per share amounts) Year Ended March 31, 2011 (a) Amortization Ac

  26. Slide 26: GAAP/Adjusted Earnings (Non-GAAP) Reconciliation

    GAAP/Adjusted Earnings (Non-GAAP) Reconciliation McKESSON CORPORATION RECONCILIATION OF GAAP OPERATING RESULTS TO ADJUSTED EARNINGS (NON-GAAP) FOR FISCAL 2007 THROUGH NINE MONTHS ENDED DECEMBER 31, 2013 (unaudited) (in millions, except per share amounts) Year Ended March 31, 2009 (a) Amortization Ac

  27. Slide 27: GAAP/Adjusted Earnings (Non-GAAP) Reconciliation

    GAAP/Adjusted Earnings (Non-GAAP) Reconciliation McKESSON CORPORATION RECONCILIATION OF GAAP OPERATING RESULTS TO ADJUSTED EARNINGS (NON-GAAP) FOR FISCAL 2007 THROUGH NINE MONTHS ENDED DECEMBER 31, 2013 (unaudited) (in millions, except per share amounts) Year Ended March 31, 2007 (a) Amortization of

  28. Slide 28: GAAP/Adjusted Earnings (Non-GAAP) Reconciliation

    GAAP/Adjusted Earnings (Non-GAAP) McKESSON CORPORATION Reconciliation RECONCILIATION OF GAAP SEGMENT FINANCIAL RESULTS TO ADJUSTED EARNINGS (NON-GAAP) FOR FISCAL 2007 THROUGH NINE MONTHS ENDED DECEMBER 31, 2013 (unaudited) (in millions) Nine Months Ended December 31, 2013 Nine Months Ended December

  29. Slide 29: GAAP/Adjusted Earnings (Non-GAAP) Reconciliation

    GAAP/Adjusted Earnings (Non-GAAP) McKESSON CORPORATION Reconciliation RECONCILIATION OF GAAP SEGMENT FINANCIAL RESULTS TO ADJUSTED EARNINGS (NON-GAAP) FOR FISCAL 2007 THROUGH NINE MONTHS ENDED DECEMBER 31, 2013 (unaudited) (in millions) Year Ended March 31, 2012 (a) Year Ended March 31, 2011 (a) Yea

  30. Slide 30: GAAP/Adjusted Earnings (Non-GAAP) Reconciliation

    GAAP/Adjusted Earnings (Non-GAAP) McKESSON CORPORATION Reconciliation RECONCILIATION OF GAAP SEGMENT FINANCIAL RESULTS TO ADJUSTED EARNINGS (NON-GAAP) FOR FISCAL 2007 THROUGH NINE MONTHS ENDED DECEMBER 31, 2013 (unaudited) (in millions) Year Ended March 31, 2009 (a) Year Ended March 31, 2008 (a) Yea

McKesson — Citi Global Healthcare Conference (February 2014) on 6ix